ARTES joined global combat against Corona with virus-like particle based platform technologies
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
-
-
Moderna announced IND Submitted to FDA for phase 2 study of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
-
Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
-
Global study to assess effects of COVID-19 in pregnancy on mothers and babies was launched
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
-
Coronavirus drifts through the air in microscopic droplets – here’s the science of infectious aerosols
On Apr. 24, 2020, Shelly Miller, Professor of Mechanical and Environmental Engineering, University of Colorado Boulder, reported that…
-
NIAID strategic plan detailed COVID-19 research priorities
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
-
Oxford University COVID-19 vaccine began human trial stage
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
-
TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infection
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
-
ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 research
On Apr. 23, 2020, BioSig Technologies announced that an article titled, ‘The IMPDH inhibitor merimepodib has similar antiviral…
-
Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
-
Researchers identified cells likely targeted by COVID-19 virus
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
-
LabCorp broadened availability of COVID-19 serological antibody tests to hospitals and healthcare organizations
On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…
-
The USDA confirmed COVID-19 in two pet cats in New York
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
-
BARDA, Tangen Biosciences partnership pursues SARS-CoV-2 diagnostic
On Apr. 22, 2020, the Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences announced teaming up…
-
SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
-
Quidel’s Lyra direct SARS-CoV-2 assay submitted for Emergency Use Authorization for molecular detection of COVID-19
On Apr. 22, 2020, Quidel announced it has applied for an Emergency Use Authorization (EUA) for the Lyraﾮ…
-
Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
-
RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
-
Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
-
Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
-
IDEXX made pet test for COVID-19 Virus available to veterinarians
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
-
COVID-19 | NIH | Therapeutics
Antiviral remdesivir prevented disease progression in monkeys with COVID-19
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
-
Roche developed new serology test to detect COVID-19 antibodies
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
-
University of Washington blood test detected past infections with new coronavirus
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
-
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
-
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
-
Soligenix announced exclusive licensing agreement for novel vaccine adjuvant from BTG Specialty Pharmaceuticals
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
-
Accelerate Diagnostics and BioCheck announced commercial supply and collaboration agreement for SARS-CoV-2 antibody tests
On Apr. 15, 2020, Accelerate Diagnostics announced they have entered into a commercial supply and collaboration agreement. Under…
-
FDA approved initiation of Humanigen’s phase III study of lenzilumab in COVID-19 patients
On Apr. 15, 2020, Humanigen announced that U.S. Food and Drug Administration (FDA) had given permission to commence…
-
Orthoﾒs total antibody test for COVID-19 received Emergency Use Authorization from FDA
On Apr. 15, 2020, the FDA announced it granted Emergency Use Authorization to Ortho Clinical Diagnosticsﾒ total antibody…
